NVP Associates
Latest statistics and disclosures from NVP Associates's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MBX, ZBIO, BLLN, OMDA, TALK, and represent 98.61% of NVP Associates's stock portfolio.
- Added to shares of these 1 stock: BLLN (+$42M).
- Started 1 new stock position in BLLN.
- NVP Associates was a net buyer of stock by $42M.
- NVP Associates has $255M in assets under management (AUM), dropping by 53.70%.
- Central Index Key (CIK): 0001545692
Tip: Access up to 7 years of quarterly data
Positions held by NVP Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for NVP Associates
NVP Associates holds 6 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Mbx Biosciences (MBX) | 26.4 | $67M | 2.1M | 31.54 |
|
|
| Zenas Biopharma (ZBIO) | 26.2 | $67M | 1.8M | 36.31 |
|
|
| Billiontoone Cl A (BLLN) | 16.5 | $42M | NEW | 513k | 81.84 |
|
| Omada Health (OMDA) | 15.6 | $40M | 2.5M | 15.78 |
|
|
| Talkspace (TALK) | 13.9 | $36M | 9.8M | 3.63 |
|
|
| Grove Collaborative Hold Com Cl A (GROV) | 1.4 | $3.5M | 3.2M | 1.10 |
|
Past Filings by NVP Associates
SEC 13F filings are viewable for NVP Associates going back to 2022
- NVP Associates 2025 Q4 filed Feb. 17, 2026
- NVP Associates 2025 Q3 filed Nov. 14, 2025
- NVP Associates 2025 Q2 filed Aug. 14, 2025
- NVP Associates 2025 Q1 filed May 12, 2025
- NVP Associates 2024 Q4 filed Feb. 10, 2025
- NVP Associates 2024 Q3 filed Nov. 12, 2024
- NVP Associates 2024 Q2 filed Aug. 13, 2024
- NVP Associates 2024 Q1 filed May 10, 2024
- NVP Associates 2023 Q4 filed Feb. 14, 2024
- NVP Associates 2023 Q3 filed Nov. 8, 2023
- NVP Associates 2023 Q2 filed Aug. 1, 2023
- NVP Associates 2023 Q1 filed May 15, 2023
- NVP Associates 2022 Q4 filed Feb. 14, 2023